Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Merck
QuintilesIMS
Express Scripts
AstraZeneca
Julphar
Johnson and Johnson
Cerilliant
Citi

Generated: July 22, 2018

DrugPatentWatch Database Preview

Secretin synthetic human - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for secretin synthetic human and what is the scope of secretin synthetic human patent protection?

Secretin synthetic human
is the generic ingredient in one branded drug marketed by Chirhoclin and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for secretin synthetic human. One supplier is listed for this compound.
Summary for secretin synthetic human

US Patents and Regulatory Information for secretin synthetic human

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chirhoclin CHIRHOSTIM secretin synthetic human FOR SOLUTION;INTRAVENOUS 021256-002 Jun 21, 2007 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Chirhoclin CHIRHOSTIM secretin synthetic human FOR SOLUTION;INTRAVENOUS 021256-001 Apr 9, 2004 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
McKesson
UBS
Deloitte
AstraZeneca
Boehringer Ingelheim
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.